Taro to Announce Second Quarter Results on November 8, 2016

Earnings Call to Discuss Results to be Conducted Wednesday, November 9 at 8:30 am ET

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2016, on Tuesday, November 8, 2016.

The Company will conduct an earnings call at 8:30 am ET on Wednesday, November 9, 2016, where senior management will discuss the Company’s performance and answer questions from participants.

The release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:30 am ET on Wednesday, November 9, 2016)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events

Event		Date and time		Telephone number/ website
Earnings release		November 8, 2016		www.taro.com
Earnings conference call		8:30 am ET Wednesday, November 9, 2016		Participant Toll-Free Dial-In Number: +1 (844) 421-0601 Participant International Dial-In Number: +1 (716) 247-5800 ID: 10641252   Via audio webcast, details of which will be made available on www.taro.com
Replay of conference call		November 9, 2016 to November 25, 2016		+ 1 (855) 859-2056 or +1 (855) 537-3406 ID: 10641252   Via audio webcast playback, details of which will be made available on www.taro.com

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Taro Pharmaceutical Industries Ltd.c/o Taro Pharmaceuticals U.S.A., Inc.Three Skyline DriveHawthorne, New York 10532(NYSE: TARO)

View source version on businesswire.com: http://www.businesswire.com/news/home/20161031006247/en/

Taro Pharmaceutical Industries Ltd.
Mariano Balaguer, 914-345-9001
VP, CFO & CAO
[email protected]
or
William J. Coote, 914-345-9001
[email protected]

Source: Taro Pharmaceutical Industries Ltd.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• CrowdStrike shares jump on earnings beat, raised outlook
• Ooma (OOMA) Tops Q2 EPS by 2c; offers guidance
• CuriosityStream names Sean Piche as CFO, effective September 1